Methods for the Development and Analysis of Human Primary Airway Epithelia

about

Methods for the Development and Analysis of Human Primary Airway Epithelia

Item

http://www.wikidata.org/entity/Q58707821

description

article

@en

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Methods for the Development and Analysis of Human Primary Airway Epithelia

@en

Methods for the Development and Analysis of Human Primary Airway Epithelia

@nl

type

Item

label

Methods for the Development and Analysis of Human Primary Airway Epithelia

@en

Methods for the Development and Analysis of Human Primary Airway Epithelia

@nl

prefLabel

Methods for the Development and Analysis of Human Primary Airway Epithelia

@en

Methods for the Development and Analysis of Human Primary Airway Epithelia

@nl

P1476

In vitro Methods for the Development and Analysis of Human Primary Airway Epithelia

@en

P2093

Ambra Gianotti

http://www.w3.org/2001/XMLSchema#string

Emanuela Caci

http://www.w3.org/2001/XMLSchema#string

P2860

Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770

TEER measurement techniques for in vitro barrier model systems

Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening.

Radiation induces diffusible feeder cell factor(s) that cooperate with ROCK inhibitor to conditionally reprogram and immortalize epithelial cells.

Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809.

Spontaneous production of transforming growth factor-beta 2 by primary cultures of bronchial epithelial cells. Effects on cell behavior in vitro

Transepithelial electrical measurements with the Ussing chamber.

Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.

Nasal epithelial cells as surrogates for bronchial epithelial cells in airway inflammation studies.

Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis.

P304

1176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.01176

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Livia Delpiano

P577

2018-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30416443

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

6212516

http://www.w3.org/2001/XMLSchema#string